|
Molecular properties generated using the CDK |
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes (source: FDA (1962)) |
| Prodrug | capecitabine, floxuridine |
IUPAC Name ![]() |
| 5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 1421 | fluorouracil |
Synonyms ![]() |
| Adrucil® |
| Carac® |
Database Links ![]() |
|
| CAS Registry No. | 51-21-8 |
| ChEMBL Ligand | CHEMBL185 |
| DrugBank Ligand | DB00544 |
| PubChem CID | 3385 |
| RCSB PDB Ligand | URF |
| Search Google for chemical match using the InChIKey | GHASVSINZRGABV-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | GHASVSINZRGABV |
| Search PubMed clinical trials | fluorouracil |
| Search PubMed titles | fluorouracil |
| Search PubMed titles/abstracts | fluorouracil |
| Wikipedia | 5-fluorouracil |
| Comments |
| Fluoroacil is the active metabolite of the prodrugs capecitabine and floxuridine. |